Article Details
Retrieved on: 2024-12-28 06:19:42
Tags for this article:
Click the tags to see associated articles and topics
Summary
AusperBio Therapeutics focuses on biopharma innovations, particularly oligonucleotide therapies, to cure chronic hepatitis B. Recent funding supports Phase 2 trials and global expansion, leveraging their proprietary Med-Oligo™ platform for advanced ASO therapies.
Article found on: www.finsmes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here